Brief: Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
03/12/2024 12:39
Dec 3 (Reuters) - Plus Therapeutics Inc PSTV.O :
* PLUS THERAPEUTICS EXPANDS STRATEGIC AGREEMENT WITH TELIX
ISOTHERAPEUTICS GROUP FOR RHENIUM-186 RADIOISOTOPE SUPPLY
Source text: ID:nGNX6RVL7v
Further company coverage: PSTV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer